Global Phasing Puts Research Goals First as it Augments Structure Determination Consortium | GenomeWeb

In the relatively obscure world of x-ray crystallography software development, it seems one company has decided to go out of its way to create a low profile. Global Phasing, an eight-person x-ray crystallography software developer based in Cambridge, UK, doesn’t have much of a website—just a portal for members of its research consortium—and in contrast to other companies developing bioinformatics tools, doesn’t make too much of a fuss about itself.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.